'Real-life' experience in asthmatic children treated with omalizumab up to six-years follow-up.
Folqué MM, Lozano J, Riggioni C, Piquer M, Álvaro M, Machinena A, Giner MT, Domínguez O, Jiménez-Feijoo RM, Dias da Costa M, Plaza AM.
Folqué MM, et al. Among authors: plaza am.
Allergol Immunopathol (Madr). 2019 Jul-Aug;47(4):336-341. doi: 10.1016/j.aller.2018.09.009. Epub 2018 Nov 30.
Allergol Immunopathol (Madr). 2019.
PMID: 30509559